Gladius Capital Management LP Organogenesis Holdings Inc. Transaction History

Gladius Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$2.28 - $3.03 $3,226 - $4,287	1,415 Added 13.83%	11,645 $32,000
Q1 2024 May 14, 2024	BUY	$2.61 - $4.49 $26,700 - $45,932	10,230 New	10,230 $29,000
Q1 2023 Dec 18, 2023	BUY	$1.89 - $2.93 $26,144 - $40,530	13,833 New	13,833 $29,000
Q1 2023 May 09, 2023	BUY	$1.89 - $2.93 $226 - $351	120 Added 0.88%	13,833 $30,000
Q4 2022 Dec 18, 2023	BUY	$2.48 - $3.43 $34,008 - $47,035	13,713 New	13,713 $36,000
Q4 2022 Feb 02, 2023	BUY	$2.48 - $3.43 $8,647 - $11,960	3,487 Added 34.1%	13,713 $37,000
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $32,109 - $65,753	10,226 New	10,226 $34,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $505M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Gladius Capital Management LP with notifications on news.